Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

25.31 -1.85 (-6.81%)
Streaming Delayed Price Updated: 2:46 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why Moderna (MRNA) Stock Is Falling Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an... 
Via StockStory
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Gapping S&P500 stocks in Monday's session
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends. 
Via Chartmill
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday. 
Via Benzinga
Why Moderna (MRNA) Stock Is Trading Lower Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock retreated, giving back some of the strong gains from the previous session that were fueled by... 
Via StockStory
Exploring the top movers within the S&P500 index during today's session.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session. 
Via Chartmill
Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On?
Moderna shares are trading lower Friday afternoon, giving back a portion of gains seen Thursday. 
Via Benzinga
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of... 
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
AI Revolutionizes Pharma Supply Chains: A New Era of Localized Resilience and Efficiency
The pharmaceutical industry is experiencing a profound and immediate transformation as Artificial Intelligence (AI) becomes a strategic imperative for localizing supply chains, fundamentally enhancing... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
Discover which S&P500 stocks are making waves on Friday.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Moderna Ignites Biotech Sector with Deal Talk Surge Amidst Broader Healthcare Woes
October 30, 2025 – While the broader S&P 500 Healthcare sector navigated a day of mixed to negative performance, a singular beacon of optimism emerged from the biotechnology landscape today as Moderna... 
Via MarketMinute
Topics Intellectual Property Stocks
Discover which S&P500 stocks are making waves on Thursday.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Moderna Stock Rallies On Reports Of Company Entering Talks With A Drugmaker For A Potential Deal
According to a report from Seeking Alpha, citing Stat News, Moderna has held talks with at least one large drugmaker. 
Via Stocktwits
Thursday's session: top gainers and losers in the S&P500 index
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Is Moderna Inc Gaining or Losing Market Support?
 
Via Benzinga
1 S&P 500 Stock to Research Further and 2 We Find Risky
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
Uncover the latest developments among S&P500 stocks in today's session.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares... 
Via MarketMinute
Topics Earnings Supply Chain
Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection
Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven and financial guidance. 
Via Benzinga
Moderna Topples, Threatening Its 50-Day Line, After A Key Vaccine Bites The Dust
The company is scrapping its study in congenital CMV after the vaccine proved just 6% to 23% effective. 
Via Investor's Business Daily
Wondering what's happening in today's S&P500 pre-market session?
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment. 
Via Chartmill
Moderna Stock Slides After-Hours On CMV Vaccine Failure In Phase 3 Trial — Retail Traders Warn Of ‘Endless’ Cash Burn
The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified. 
Via Stocktwits
What's going on in today's after hours session: S&P500 movers
Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Global Economic Freedom in Retreat: A Four-Year Decline Signals Looming Market Shifts
Washington D.C., October 22, 2025 – The world stands at a critical juncture as the 2025 Economic Freedom of the World index, prominently released by the Fraser Institute in collaboration with the Cato... 
Via MarketMinute
Topics Bonds Brexit Economy
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.
The biotech's innovative qualities will come in handy. 
Via The Motley Fool
Should You Buy Moderna Right Now?
Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough. 
Via The Motley Fool
Topics Bonds
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.